These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6823996)

  • 1. Compatibility and stability of clindamycin phosphate with intravenous fluids.
    Porter WR; Johnson CA; Cohon MS; Gillespie W
    Am J Hosp Pharm; 1983 Jan; 40(1):91-4. PubMed ID: 6823996
    [No Abstract]   [Full Text] [Related]  

  • 2. Cimetidine hydrochloride compatibility. II: room temperature stability in intravenous infusion fluids.
    Yuhas EM; Lofton FT; Mayron D; Baldinus JG; rosenberg HA
    Am J Hosp Pharm; 1981 Jun; 38(6):879-81. PubMed ID: 7246564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cimetidine hydrochloride compatibility. I: Chemical aspects and room temperature stability in intravenous infusion fluids.
    Rosenberg HA; Dougherty JT; Mayron D; Baldinus JG
    Am J Hosp Pharm; 1980 Mar; 37(3):390-2. PubMed ID: 7369222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A stability and compatibility evaluation of a novel calcium entry blocker in admixture preparations.
    Kishnani NS; Visor GC
    J Parenter Sci Technol; 1988; 42(2):68-71. PubMed ID: 3385545
    [No Abstract]   [Full Text] [Related]  

  • 5. Stability and compatibility studies of cefaloridine, cefuroxime and ceftazidime with PVC infusion bags.
    Faouzi MA; Dine T; Luyckx M; Gressier B; Brunet C; Goudaliez F; Mallevais ML; Cazin M; Cazin JC
    Pharmazie; 1994 Jun; 49(6):425-7. PubMed ID: 8047543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the stability and compatibility of drugs in infusion fluids. VI. Factors affecting the stability of ampicillin.
    Stjernström G; Olson OT; Nyqvist H; Lundgren P
    Acta Pharm Suec; 1978; 15(1):33-50. PubMed ID: 25558
    [No Abstract]   [Full Text] [Related]  

  • 7. Compatibility and stability of dobutamine hydrochloride with large-volume parenterals and selected additives.
    Kirschenbaum HL; Aronoff W; Piltz GW; Perentesis GP; Cutie AJ
    Am J Hosp Pharm; 1983 Oct; 40(10):1690-1. PubMed ID: 6638033
    [No Abstract]   [Full Text] [Related]  

  • 8. Compatibility and stability of labetalol hydrochloride in commonly used intravenous solutions.
    Yuen PH; Taddei CR; Wyka BE; Chaudry IA
    Am J Hosp Pharm; 1983 Jun; 40(6):1007-9. PubMed ID: 6869384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The compatibility and stability of midazolam and dexamethasone in infusion solutions.
    Good PD; Schneider JJ; Ravenscroft PJ
    J Pain Symptom Manage; 2004 May; 27(5):471-5. PubMed ID: 15120775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug additive compatibility--a manufacturer's concern.
    Nedich RL
    Bull Parenter Drug Assoc; 1973; 27(5):228-33. PubMed ID: 4201030
    [No Abstract]   [Full Text] [Related]  

  • 11. Methylprednisolone sodium succinate in pediatric parenteral nutrition: influence of vehicle injection.
    Gellis C; Sautou-Miranda V; Jarrige JF; Grand-Boyer A; Bleyzac N; Chopineau J
    Clin Nutr; 2004 Aug; 23(4):515-25. PubMed ID: 15297087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability and compatibility of minocycline hydrochloride and rifampin in intravenous solutions at various temperatures.
    Pearson SD; Trissel LA
    Am J Hosp Pharm; 1993 Apr; 50(4):698-702. PubMed ID: 8470688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compatibility of tramadol hydrochloride injection with selected drugs and solutions.
    Abanmy NO; Zaghloul IY; Radwan MA
    Am J Health Syst Pharm; 2005 Jun; 62(12):1299-302. PubMed ID: 15947129
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the stability and compatibility of drugs in infusion fluids. III. Factors affecting the stability of cloxacillin.
    Landersjö L; Källstrand G; Lungren P
    Acta Pharm Suec; 1974 Dec; 11(6):563-80. PubMed ID: 237403
    [No Abstract]   [Full Text] [Related]  

  • 15. Bretylium tosylate intravenous admixture compatibility. I: Stability in common large-volume parenteral solutions.
    Lee YC; Baaske DM; Amann AH; Carter JE; Mooers MA; Wagenknecht DM; Lai CM
    Am J Hosp Pharm; 1980 Jun; 37(6):803-8. PubMed ID: 7395875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of clindamycin phosphate, ranitidine hydrochloride, and piperacillin sodium in polyolefin containers.
    Sarkar MA; Rogers E; Reinhard M; Wells B; Karnes HT
    Am J Hosp Pharm; 1991 Oct; 48(10):2184-6. PubMed ID: 1781477
    [No Abstract]   [Full Text] [Related]  

  • 17. Cimetidine hydrochloride compatibility. III: Room temperature stability in drug admixtures.
    Yuhas EM; Lofton FT; Rosenberg HA; Mayron D; Baldinus JG
    Am J Hosp Pharm; 1981 Dec; 38(12):1919-22. PubMed ID: 7325173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of paclitaxel and fluconazole during simulated Y-site administration.
    Burm JP; Choi JS; Jhee SS; Chin A; Ulrich RW; Gill MA
    Am J Hosp Pharm; 1994 Nov; 51(21):2704-6. PubMed ID: 7856586
    [No Abstract]   [Full Text] [Related]  

  • 19. Parenteral development of clindamycin-2-phosphate.
    Riebe KW; Oesterling TO
    Bull Parenter Drug Assoc; 1972; 26(3):139-46. PubMed ID: 5035118
    [No Abstract]   [Full Text] [Related]  

  • 20. Stability of dexamethasone sodium phosphate, diphenhydramine hydrochloride, lorazepam, and metoclopramide hydrochloride in portable infusion-pump reservoirs.
    Stiles ML; Allen LV; Prince SJ; Holland JS
    Am J Hosp Pharm; 1994 Feb; 51(4):514-7. PubMed ID: 8017420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.